← FDA Drug Approvals (Drugs@FDA)
BUPIVACAINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANTHEA PHARMA · Approved 2026-04-22
Drug application
- FDA Application #
ANDA220493- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BUPIVACAINE HYDROCHLORIDE
- Generic name
- BUPIVACAINE HYDROCHLORIDE
- Active ingredients
- BUPIVACAINE HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- ANTHEA PHARMA
- Manufacturer
- Anthea Pharma Private Limited
- First approval
- 2026-04-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown